The Opportunity
Project Mars is a biotech company dedicated to developing innovative solutions to improve patient outcomes globally. Its mission is to alleviate the suffering caused by infections by creating effective solutions that transform point-of-care diagnostics.
The company leverages clinical expertise to challenge existing assumptions and deliver impactful biotech innovations – it holds 25 patents (with a further 5 pending) and 1 trademark.
Project Mars is pre-revenue and currently at the prototype development stage of its research and development, with mass-market penetration expected in 2027.
Offers are invited to acquire the shares and/or assets and intellectual property of Project Mars.
Key Acquisition Highlights
- Intellectual property – 25+ patents and 1 trademark
- Patented lightweight portable device, comprising proprietary technology
- Technology that reduces testing times from days to hours
- Simplified technology, meaning very little training is required by health care professionals
- Developed to save up to 8 million lives worldwide annually
- Founder and research team willing to stay with the company post-acquisition to finish the project
Recent Comments